ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS
EPRA International Journal of Research & Development (IJRD) · 2026-08-17 · 91
DOI: 10.36713/epra28874 ↗At a glance
Journal article in EPRA International Journal of Research & Development (IJRD), published online on 2026-08-17. Written by Harshveer Singh Jaitawat and 3 co-authors.
Abstract (original language)
Background
Artificial intelligence-assisted drug discovery can reduce the chemical search space by integrating molecular generation, drug-likeness assessment and structure-based docking. However, computational rankings require careful validation and should be interpreted as prioritization rather than evidence of therapeutic efficacy.
Objectives
To integrate AI-assisted molecular design, physicochemical/ADMET screening, molecular docking and ligand–protein interaction analysis for identification of potential leads across selected cancer, metabolic and neurodegenerative targets.
Methods
A documented computational workflow was applied to five ligand-bound human targets—EGFR (1M17), KRAS G12C (5V71), DPP-4 (1X70), PTP1B (1C83) and AChE (4EY7). The supplied thesis dataset described progressive filtering of a 1350-member virtual library to 14 final candidates, followed by drug-likeness/ADMET assessment, AutoDock Vina docking and redocking validation. Candidate prioritization integrated docking score, target-relevant interactions and computational pharmacokinetic/toxicity characteristics.
Results
All five reference systems passed the predefined redocking criterion of
Cite
APA
Jaitawat, H. S., Sharma, D. C., Udawat, D. H., & Naruka, D. P. (2026). ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS. EPRA International Journal of Research & Development (IJRD), 91. https://doi.org/10.36713/epra28874
Vancouver
Jaitawat HS, Sharma DC, Udawat DH, Naruka DP. ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS. EPRA International Journal of Research & Development (IJRD). 2026:91. doi:10.36713/epra28874
BibTeX
@article{Jaitawat2026,
author = {Jaitawat, Harshveer Singh and Sharma, Dr. C.S. and Udawat, Dr. H.S. and Naruka, Dr. P.S.},
title = {ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS},
journal = {EPRA International Journal of Research & Development (IJRD)},
year = {2026},
pages = {91},
doi = {10.36713/epra28874}
}
EUVIMED